WO2001003573A3 - Method of diagnosis of cardiac hypertrophy - Google Patents

Method of diagnosis of cardiac hypertrophy Download PDF

Info

Publication number
WO2001003573A3
WO2001003573A3 PCT/GB2000/002521 GB0002521W WO0103573A3 WO 2001003573 A3 WO2001003573 A3 WO 2001003573A3 GB 0002521 W GB0002521 W GB 0002521W WO 0103573 A3 WO0103573 A3 WO 0103573A3
Authority
WO
WIPO (PCT)
Prior art keywords
cardiac hypertrophy
diagnosis
cardiotrophin
predisposition
assaying
Prior art date
Application number
PCT/GB2000/002521
Other languages
French (fr)
Other versions
WO2001003573A2 (en
Inventor
Anthony Michael Heagerty
Original Assignee
Univ Manchester
Anthony Michael Heagerty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9915881.8A external-priority patent/GB9915881D0/en
Application filed by Univ Manchester, Anthony Michael Heagerty filed Critical Univ Manchester
Priority to JP2001508865A priority Critical patent/JP2003504602A/en
Priority to CA002380339A priority patent/CA2380339A1/en
Priority to EP00942228A priority patent/EP1196781A2/en
Priority to AU56933/00A priority patent/AU5693300A/en
Publication of WO2001003573A2 publication Critical patent/WO2001003573A2/en
Publication of WO2001003573A3 publication Critical patent/WO2001003573A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method for diagnosing or detecting a predisposition to cardiac hypertrophy comprising assaying a sample of human bodily fluid in vitro for the level of cardiotrophin-1 (CT-1) contained therein and uses thereof.
PCT/GB2000/002521 1999-07-08 2000-06-29 Method of diagnosis of cardiac hypertrophy WO2001003573A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001508865A JP2003504602A (en) 1999-07-08 2000-06-29 Diagnosis method
CA002380339A CA2380339A1 (en) 1999-07-08 2000-06-29 Method of diagnosis of cardiac hypertrophy
EP00942228A EP1196781A2 (en) 1999-07-08 2000-06-29 Method of diagnosis of cardiac hypertrophy
AU56933/00A AU5693300A (en) 1999-07-08 2000-06-29 Method of diagnosis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14277599P 1999-07-08 1999-07-08
GBGB9915881.8A GB9915881D0 (en) 1999-07-08 1999-07-08 Methods of diagnosis
GB9915881.8 1999-07-08
US60/142,775 1999-07-08

Publications (2)

Publication Number Publication Date
WO2001003573A2 WO2001003573A2 (en) 2001-01-18
WO2001003573A3 true WO2001003573A3 (en) 2001-10-11

Family

ID=26315738

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/002521 WO2001003573A2 (en) 1999-07-08 2000-06-29 Method of diagnosis of cardiac hypertrophy

Country Status (6)

Country Link
EP (1) EP1196781A2 (en)
JP (1) JP2003504602A (en)
CN (1) CN1370277A (en)
AU (1) AU5693300A (en)
CA (1) CA2380339A1 (en)
WO (1) WO2001003573A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006117410A1 (en) * 2005-04-28 2006-11-09 Proyecto De Biomedicina Cima, S.L. Use of a c-terminal fragment of cardiotrophin-1 as a cardiotrophin-1 marker
DE102006034142A1 (en) * 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Method for controlling the therapy of heart failure patients by the in vitro determination of threshold levels of vasoactive peptides
CN108254576B (en) * 2018-01-25 2020-08-04 南京医科大学 Application of adenine nucleotide transporter 1

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571893A (en) * 1994-04-25 1996-11-05 Genentech, Inc. Cardiac hypertrophy factor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571893A (en) * 1994-04-25 1996-11-05 Genentech, Inc. Cardiac hypertrophy factor

Also Published As

Publication number Publication date
WO2001003573A2 (en) 2001-01-18
EP1196781A2 (en) 2002-04-17
CN1370277A (en) 2002-09-18
AU5693300A (en) 2001-01-30
CA2380339A1 (en) 2001-01-18
JP2003504602A (en) 2003-02-04

Similar Documents

Publication Publication Date Title
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
MXPA02011478A (en) Stabilized tetrazolium-phenazine reagent compositions and methods for using the same.
AU1726797A (en) A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
MXPA02011479A (en) Stabilized tetrazolium reagent compositions and methods for using the same.
WO2004040253A3 (en) Secretion-testing article
WO2004042346A3 (en) Methods and compositions for diagnosing and monitoring transplant rejection
EP1314395A3 (en) Method for multi-site skin testing
AU2002249819A1 (en) Measurement testing of blood specimens
GB2344897A (en) System and method for measuring a bioanalyte such as lactate
WO2001008551A3 (en) Luminous glucose monitoring device
PL354423A1 (en) Method of biological fluid sampling and making corresponding analyte measurements as well as an electrochemical cell, apparatus and system therefor
AU2003256132A1 (en) Automatic blood pressure measuring instrument and method thereof
CA2332112A1 (en) Monitoring of physiological analytes
CA2435550A1 (en) System for monitoring the concentration of analytes in body fluids
EP0922954A3 (en) Method for recognizing the presence of sample fluid on a test strip by evaluating first and second derivatives
CA2263063A1 (en) Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CA2421007A1 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2000018954A3 (en) Use of pex in the treatment of metabolic bone diseases
WO2002098280A3 (en) Method for detecting infectious agents using computer controlled automated image analysis
HK1131641A1 (en) A diagnostic test for bacterial vaginosis
WO2004021008A3 (en) Methods for detecting breast and ovarian cancer
WO2001003573A3 (en) Method of diagnosis of cardiac hypertrophy
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
WO2004008140A3 (en) Plasma urotensin in human heart failure
CA2172243A1 (en) Method for quantifying bpi in body fluids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000942228

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 56933/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2380339

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2002/00168/DE

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 008115834

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2000942228

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000942228

Country of ref document: EP